ENTITY
Shanghai Fosun Pharmaceutical (Group)

Shanghai Fosun Pharmaceutical (Group) (600196 CH)

112
Analysis
Health CareChina
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a pharmaceutical company. Through its subsidiaries, the Company manufactures genetic medicines, Chinese traditional medicines, diagnostic products, and medical instruments, provides technology, marketing, and advertising services, as well as invests in import and export trading.
more
01 Dec 2024 06:30

Last Week in Event SPACE: Keisei Electric Railway, Vitasoy, NEC Network, ESR Group

It’s Sunday! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed during the...

Logo
599 Views
Share
01 Dec 2024 06:25

Mostly) Asia-Pac M&A: SG Fleet, Shandong Hi-Speed New Energy, HPI, Capitol Health, Henlius, 7 & I

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
589 Views
Share
25 Nov 2024 09:52

Henlius (2696 HK): The Spread Should Narrow After NDRC Approval

Currently trading at an excessive gross/annualised spread of 21.5%/39.6%, assuming late-June payment. I'd get involved here. I'd pay up to HK$22.70...

Logo
625 Views
Share
25 Nov 2024 08:50

Shanghai Henlius Biotech (2696.HK) Privatization Update - These Are the Potential Risks Behind

The Offeror has received the approval from NDRC and will continue to liaise with local authorities of MOC and prepare for the registration filing...

Logo
951 Views
Share
25 Nov 2024 01:26

Merger Arb Mondays (25 Nov) - Seven & I, Fuji Soft, ID&EH, Arcadium, Henlius, Canvest, GAPack

This week, the highest gross spreads are Henlius (21.5%), Canvest (13.7%), Get Nice Financial (13.3%), Shinko Electric (12.7%), Arcadium Lithium...

Logo
518 Views
Share
x